Show-Hong Duh, Ph.D., is the Advisor Board Member for clinical pathology at ABS. Dr. Duh is Associate Professor of Pathology at University of Maryland School of Medicine since 2005. Dr. Duh held a BS degree in Pharmacy in 1970 at Taipei, Taiwan. Dr. Duh held a M.S. degree inPharmaceutical Sciences in 1981 at North Dakota State University, Fargo, ND. Show-Hong graduated from North Dakota State University in 1985 held a Ph.D. degree in Biochemistry. Dr. Duh held a certification from American Board of Clinical Chemistry in 1992. Dr. Duh is Associate Director since 1989 in the Core/Clinical Chemistry Laboratory at University of Maryland Medical Center. Dr. Duh received Joseph H. Roe Award from American Association for Clinical Chemistry Capital Section (2000), and Show-Hong has more than 20 years experience in medical device evaluations that were cooperated with the USFDA’s numerous clinical research projects. Dr. Duh Co-invented a patent regarding methods for evaluation of therapies and predicting clinical outcome related to coronary conditions (US patent 6,662,114).
Dr. Duh’s major research interests are in application of statistics in laboratory medicine, particularly in quality control protocol, method/instrument evaluation, and methods of determination of detection limit for qualitative assays; application of tandem mass spectrometry in the clinical laboratory analysis; new methodology for automated chemiluminescence immunoassay. Dr. Duh has numerous peer reviewed publications.
Advisory Board Chairman in Science and Technology
Peter T. Kissinger, Ph.D., is the founder of Bioanalytical Systems, Inc., which he led from 1974-2007, and is Professor of Chemistry at Purdue University, West Lafayette, Indiana. Dr. Kissinger received a B.S. in Chemistry (1966) from Union College, Schenectady, N.Y. and a Ph.D. in Analytical Chemistry (1970) from the University of North Carolina in Chapel Hill. Prior to joining the faculty at Purdue in 1975, Kissinger was a Research Associate at the University of Kansas (1970-1972) and an Assistant Professor at Michigan State University (1972-1975). He founded BASi in 1974. Headquartered in West Lafayette, Indiana, BASi also has operations in Evansville; Baltimore; McMinnville, OR; and the U.K. The company manufactures instrumentation and develops software for pharmaceutical research, and carries out contract bioanalytical, pharmacological and toxicological research for pharmaceutical and biotechnology companies. BASi Vetronics manufactures instrumentation for veterinary medicine. Dr. Kissinger’s academic research has involved the study of modern liquid chromatography techniques, and in vivo methodology for drug metabolism and the neurosciences. Dr. Kissinger has published more than 230 scientific papers and is a Fellow of the American Association of Pharmaceutical Scientists and the American Association for the Advancement of Science. In 2005, he became the Chairman of Prosolia, which markets mass spectrometry innovations for life science, industrial and homeland security applications. In 2007, he and Candice Kissinger founded Phlebotics, Inc., a medical device company focused on diagnostic information for intensive care medicine. In 2008, Professor Kissinger is the Associate Head of the Department of Chemistry at Purdue University.